| Filed On | Filing |
|---|---|
| 18 Jun 2026 |
Form 4: Salva Francisco D., Director
Received 4,064,050 shares by conversion |
| 22 Apr 2026 |
Form 4: Staskey Norm, Chief Financial Officer
Granted 35,524 Stock Options (Right To Buy) |
| 22 Apr 2026 |
Form 4: Salva Francisco D., Director
Granted 220,879 Stock Options (Right To Buy) |
| 22 Apr 2026 |
Form 4: Whitfill Travis, Director
Granted 64,300 Stock Options (Right To Buy) |
| 20 Mar 2026 |
Form 4: Salva Francisco D., Director
Acquired 500 Series A Convertible Non-Redeemable Preferred Stock (Open Market Purchase) · Acquired 4,064,050 Series B Warrants (Open Market Purchase) · Acquired 4,064,050 Series C Warrants (Open Market Purchase) |
| 22 Dec 2025 |
Form 4: Whitfill Travis, Director
Granted 23,724 Stock Options (Right To Buy) |
| 22 Dec 2025 |
Form 4: Salva Francisco D., Director
Granted 59,309 Stock Options (Right To Buy) |
| 22 Dec 2025 |
Form 4: Ryan Barbara, Director
Granted 3,003 Stock Options (Right To Buy) |
| 22 Dec 2025 |
Form 4: Staskey Norm, Chief Financial Officer
Granted 15,015 Stock Options (Right To Buy) |
| 22 Dec 2025 |
Form 4: Schroer John R., Director
Granted 3,003 Stock Options (Right To Buy) |
| 01 Apr 2024 |
Form 4: Staskey Norm, Chief Financial Officer
Bought 47,600 shares ($10K) |
| 15 Feb 2024 |
Form 4: Staskey Norm, Chief Financial Officer
Bought 3,300 shares ($990) |
| 15 Feb 2024 |
Form 4: Whitfill Travis, Director
Bought 15,000 shares ($4.5K) |
| 15 Feb 2024 |
Form 4: Salva Francisco D., Director
Bought 333,300 shares ($100K) |
| 03 Oct 2023 |
Form 4: Staskey Norm, Chief Financial Officer
Granted 10,000 Stock Options (Right To Buy) |
| 03 Oct 2023 |
Form 4: Whitfill Travis, Director
Granted 10,000 Stock Options (Right To Buy) |
| 03 Oct 2023 |
Form 4: Schroer John R., Director
Granted 10,000 Stock Options (Right To Buy) |
| 03 Oct 2023 |
Form 4: Ryan Barbara, Director
Granted 10,000 Stock Options (Right To Buy) |
| 24 Jul 2023 |
Form 4: Bayer Healthcare Llc, 10% owner and 3 others
Received 1,307,401 shares by conversion |
| 26 Jun 2023 |
Form 4: McClary Andrew, Director
Received 59,322 shares by conversion |
Loading...